![IJMS | Free Full-Text | ACE2 and Innate Immunity in the Regulation of SARS-CoV-2-Induced Acute Lung Injury: A Review IJMS | Free Full-Text | ACE2 and Innate Immunity in the Regulation of SARS-CoV-2-Induced Acute Lung Injury: A Review](https://pub.mdpi-res.com/ijms/ijms-22-11483/article_deploy/html/images/ijms-22-11483-g001.png?1635159233)
IJMS | Free Full-Text | ACE2 and Innate Immunity in the Regulation of SARS-CoV-2-Induced Acute Lung Injury: A Review
![JCI Insight - IgM anti-ACE2 autoantibodies in severe COVID-19 activate complement and perturb vascular endothelial function JCI Insight - IgM anti-ACE2 autoantibodies in severe COVID-19 activate complement and perturb vascular endothelial function](https://df6sxcketz7bb.cloudfront.net/manuscripts/158000/158362/medium/jci.insight.158362.ga.jpg)
JCI Insight - IgM anti-ACE2 autoantibodies in severe COVID-19 activate complement and perturb vascular endothelial function
![JCI Insight - IgM anti-ACE2 autoantibodies in severe COVID-19 activate complement and perturb vascular endothelial function JCI Insight - IgM anti-ACE2 autoantibodies in severe COVID-19 activate complement and perturb vascular endothelial function](https://df6sxcketz7bb.cloudfront.net/manuscripts/158000/158362/medium/jci.insight.158362.f1.jpg)
JCI Insight - IgM anti-ACE2 autoantibodies in severe COVID-19 activate complement and perturb vascular endothelial function
![Humanized COVID‐19 decoy antibody effectively blocks viral entry and prevents SARS‐CoV‐2 infection | EMBO Molecular Medicine Humanized COVID‐19 decoy antibody effectively blocks viral entry and prevents SARS‐CoV‐2 infection | EMBO Molecular Medicine](https://www.embopress.org/cms/asset/3f68ea65-1eed-40c8-b293-51f00fe5a7cb/emmm202012828-abs-0001-m.jpg)
Humanized COVID‐19 decoy antibody effectively blocks viral entry and prevents SARS‐CoV‐2 infection | EMBO Molecular Medicine
![Evidence for an ACE2-Independent Entry Pathway That Can Protect from Neutralization by an Antibody Used for COVID-19 Therapy | mBio Evidence for an ACE2-Independent Entry Pathway That Can Protect from Neutralization by an Antibody Used for COVID-19 Therapy | mBio](https://journals.asm.org/cms/10.1128/mbio.00364-22/asset/aa0c6326-4bf0-4afd-bbf7-f05b7e765d2b/assets/images/medium/mbio.00364-22-f001.gif)
Evidence for an ACE2-Independent Entry Pathway That Can Protect from Neutralization by an Antibody Used for COVID-19 Therapy | mBio
![Is the anti-aging effect of ACE2 due to its role in the renin-angiotensin system?—Findings from a comparison of the aging phenotypes of ACE2-deficient, Tsukuba hypertensive, and Mas-deficient mice— | Hypertension Research Is the anti-aging effect of ACE2 due to its role in the renin-angiotensin system?—Findings from a comparison of the aging phenotypes of ACE2-deficient, Tsukuba hypertensive, and Mas-deficient mice— | Hypertension Research](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41440-023-01189-y/MediaObjects/41440_2023_1189_Figa_HTML.png)
Is the anti-aging effect of ACE2 due to its role in the renin-angiotensin system?—Findings from a comparison of the aging phenotypes of ACE2-deficient, Tsukuba hypertensive, and Mas-deficient mice— | Hypertension Research
![Dalbavancin binds ACE2 to block its interaction with SARS-CoV-2 spike protein and is effective in inhibiting SARS-CoV-2 infection in animal models | Cell Research Dalbavancin binds ACE2 to block its interaction with SARS-CoV-2 spike protein and is effective in inhibiting SARS-CoV-2 infection in animal models | Cell Research](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41422-020-00450-0/MediaObjects/41422_2020_450_Fig2_HTML.png)
Dalbavancin binds ACE2 to block its interaction with SARS-CoV-2 spike protein and is effective in inhibiting SARS-CoV-2 infection in animal models | Cell Research
![Dysregulation of ACE (Angiotensin-Converting Enzyme)-2 and Renin-Angiotensin Peptides in SARS-CoV-2 Mediated Mortality and End-Organ Injuries | Hypertension Dysregulation of ACE (Angiotensin-Converting Enzyme)-2 and Renin-Angiotensin Peptides in SARS-CoV-2 Mediated Mortality and End-Organ Injuries | Hypertension](https://www.ahajournals.org/cms/asset/cba73439-8ecb-47f2-9ec7-6f53d080061a/hypertensionaha.121.18295.fig05.jpg)
Dysregulation of ACE (Angiotensin-Converting Enzyme)-2 and Renin-Angiotensin Peptides in SARS-CoV-2 Mediated Mortality and End-Organ Injuries | Hypertension
![Discovery of Small Anti‐ACE2 Peptides to Inhibit SARS‐CoV‐2 Infectivity (Adv. Therap. 7/2021) - Adhikary - 2021 - Advanced Therapeutics - Wiley Online Library Discovery of Small Anti‐ACE2 Peptides to Inhibit SARS‐CoV‐2 Infectivity (Adv. Therap. 7/2021) - Adhikary - 2021 - Advanced Therapeutics - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/02f616e0-e6b3-4ba6-a775-c845938cd79e/adtp202170016-gra-0001-m.jpg)
Discovery of Small Anti‐ACE2 Peptides to Inhibit SARS‐CoV‐2 Infectivity (Adv. Therap. 7/2021) - Adhikary - 2021 - Advanced Therapeutics - Wiley Online Library
![Viruses | Free Full-Text | ACE2: The key Molecule for Understanding the Pathophysiology of Severe and Critical Conditions of COVID-19: Demon or Angel? Viruses | Free Full-Text | ACE2: The key Molecule for Understanding the Pathophysiology of Severe and Critical Conditions of COVID-19: Demon or Angel?](https://pub.mdpi-res.com/viruses/viruses-12-00491/article_deploy/html/images/viruses-12-00491-g001.png?1602190051)